ClinicalTrials.Veeva

Menu

Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients

A

Aga Khan University Hospital, Pakistan

Status

Completed

Conditions

Chronic Kidney Disease-Mineral and Bone Disorder

Study type

Observational

Funder types

Other

Identifiers

NCT05399251
ERC # 2020-3295-14097

Details and patient eligibility

About

This cross-sectional study was conducted, including those subjects tested for 1,25(OH)2D during Jan 2015-Dec 2021. Estimated glomerular filtration rate (eGFR) was calculated and subjects were classified into chronic kidney disease (CKD) stages. Associations between biochemical marker, calcium, phosphorus, magnesium, alkaline phosphatase, 1,25(OH)2D and CKD stages was determined.

Enrollment

1,553 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Data of serum 1,25(OH)2D available

Exclusion criteria

• Serum1,25(OH)2D is not available

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems